Timothy Z Yu (Stephen Yu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Combination Therapy

Pluripotent Stem Cells

Structure Activity Relationship

Top Venues

Molecular cancer therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Mary Ellen Molloy, Wade H Aaron, Manasi Barath, Mabel C Bush, Evan C Callihan, Kevin Carlin, Michael Cremin, Thomas Evans, Maria Gamez Guerrero, Golzar Hemmati, Avneel S Hundal, Llewelyn Lao, Payton Laurie, Bryan D Lemon, S Jack Lin, Jessica O'Rear, Purbasa Patnaik, Sony Sotelo Rocha, Linda Chang, Kathryn L Strobel, Laura B Valenzuela, Chi-Heng Wu, Stephen Yu, Timothy Z Yu, Banmeet S Anand, Che-Leung Law, Liping L Sun, Holger Wesche, Richard J Austin
HPN328, a Trispecific T Cell-activating Protein Construct Targeting DLL3-Expressing Solid Tumors. Molecular cancer therapeutics (2024)
Mary Ellen Molloy, Richard J Austin, Bryan D Lemon, Wade H Aaron, Vaishnavi Ganti, Adrie Jones, Susan D Jones, Kathryn L Strobel, Purbasa Patnaik, Kenneth Sexton, Laurie Tatalick, Timothy Z Yu, Patrick A Baeuerle, Che-Leung Law, Holger Wesche
Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)
Richard J Austin, Bryan D Lemon, Wade H Aaron, Manasi Barath, Patricia A Culp, Robert B DuBridge, Luke B Evnin, Adrie Jones, Anand Panchal, Purbasa Patnaik, Vanitha Ramakrishnan, Sony S Rocha, Pui Seto, Kenneth Sexton, Kathryn L Strobel, Russell Wall, Timothy Z Yu, Che-Leung Law, Patrick A Baeuerle, Holger Wesche
TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid Tumors. Molecular cancer therapeutics 20 (1) (2020)